; and (C) training and support relating to clinical case management support. . 722. Study on opioid alternatives (a) Establishment Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall carry out a study in military treatment facilities on the efficacy of opioid alternatives for pain management. (b) Report Not later than one year after the date of the enactment of this Act, the Secretary shall submit to the Committees on Armed Services of the Senate and House of Representatives a report on the results of the study under this section. Such report shall include recommendations of the Secretary regarding the use of opioid alternatives in military treatment facilities. (c) Opioid alternative defined In this section, the term opioid alternative includes the following: (1) Cryotherapy. (2) Hyperbaric oxygen therapy. (3) Sensory deprivation. 723. Program of the Department of Defense to study treatment of certain conditions using certain psychedelic substances (a) Establishment Not later than 180 days after the date of enactment of this Act, the Secretary of Defense shall establish a process to fund eligible entities to conduct research on the treatment of eligible members of the Armed Forces with a covered condition using covered psychedelic substances. Not later than 180 days after the date of the enactment of this Act, the Secretary shall designate a lead administrator to carry out the program under this section. (b) Eligible entities The Secretary may enter into a partnership and award funding under this section to any of the following: (1) A department or agency of the Federal Government or a State government. (2) An academic institution. (c) Participation in clinical trials The Secretary may authorize any member of the Armed Forces serving on active duty who is diagnosed with a covered condition to participate in a clinical trial that is conducted using funding awarded under this section and is authorized pursuant to section 505 of the Federal Food, Drug, and Cosmetic